Binect AG
XETRA:MA10
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Binect AG
XETRA:MA10
|
DE |
|
Innovaderma PLC
LSE:IDP
|
UK |
|
Tata Chemicals Ltd
NSE:TATACHEM
|
IN |
|
Yangzijiang Shipbuilding Holdings Ltd
SGX:BS6
|
CN |
|
N
|
Nordic Nanovector ASA
OSE:NANOV
|
NO |
|
Nuix Ltd
ASX:NXL
|
AU |
Wall Street
Price Targets
MA10 Price Targets Summary
Binect AG
According to Wall Street analysts, the average 1-year price target for
MA10
is 4.03 EUR
with a low forecast of 3.99 EUR and a high forecast of 4.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MA10's stock price target?
Price Target
4.03
EUR
According to Wall Street analysts, the average 1-year price target for
MA10
is 4.03 EUR
with a low forecast of 3.99 EUR and a high forecast of 4.15 EUR.
What is Binect AG's Revenue forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Binect AG's revenue is
16%.
The projected
CAGR
for the next 4 years is
5%.
What is Binect AG's Operating Income forecast?
Projected CAGR
125%
The
compound annual growth rate
of Binect AG's operating income for the next 4 years is
125%.
What is Binect AG's Net Income forecast?
Projected CAGR
61%
The
compound annual growth rate
of Binect AG's net income for the next 4 years is
61%.
